systemic-lupus-erythematosus

Documents about systemic-lupus-erythematosus

• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus#827191ClinicalTrials.gov
• CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis#912267ClinicalTrials.gov
• The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus#827976ClinicalTrials.gov
• Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus#908259ClinicalTrials.gov
• Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus#885860ClinicalTrials.gov
• Clinical association between Kikuchi׳s disease and systemic lupus erythematosus: A systematic literature review#296798Gestión del Repositorio Documental de la Universidad de Salamanca
• Interleukin23 in Systemic Lupus#826437ClinicalTrials.gov
• Systemic Lupus and Adverse Pregnancy Outcome#895515ClinicalTrials.gov
• Acthar SLE (Systemic Lupus Erythematosus)#839253ClinicalTrials.gov
• A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus#883253ClinicalTrials.gov
• Aerobic Exercise in Women With Systemic Lupus Erythematosus#870838ClinicalTrials.gov
• Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals#837011ClinicalTrials.gov
• Diversity in clinical Trials: The example of systemic lupus erythematosus#67589Europe PMC
• Hydroxychloroquine in Systemic Lupus Erythematosus#877282ClinicalTrials.gov
• BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus#905164ClinicalTrials.gov
• A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02#838716ClinicalTrials.gov
• Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)#894696ClinicalTrials.gov
• A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus#838035ClinicalTrials.gov
• A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus#842625ClinicalTrials.gov
• Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus#856232ClinicalTrials.gov
• Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)#980279ClinicalTrials.gov
• Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)#1007055ClinicalTrials.gov
• Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)#833848ClinicalTrials.gov
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus#849062ClinicalTrials.gov
• Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus#888339ClinicalTrials.gov
• Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus.#878594ClinicalTrials.gov
• A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus#448828HAL (France)
• Validation of Patient E-tool to Measure Systemic Lupus Activity#813638ClinicalTrials.gov
• A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus#812153ClinicalTrials.gov
• A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus#831985ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus#841500ClinicalTrials.gov
• Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)#866885ClinicalTrials.gov
• Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus#883638ClinicalTrials.gov
• Monitoring Lupus Nephritis Through Urinary Extracellular Vesicles#882254ClinicalTrials.gov
• Laser Acupuncture in Egyptian Systemic Lupus Females With Insulin Resistance#846211ClinicalTrials.gov
• Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study#813206ClinicalTrials.gov
• Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus#859873ClinicalTrials.gov
• An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)#904076ClinicalTrials.gov
• Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients#67674ClinicalTrials.gov
• Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus#907522ClinicalTrials.gov
• A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus#910098ClinicalTrials.gov
• Vaccination in systemic lupus erythematosus#205415Europe PMC
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease#245449ClinicalTrials.gov
• Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus#833720ClinicalTrials.gov
• Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study#853564ClinicalTrials.gov
• A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus#835823ClinicalTrials.gov
• Vitamin D Supplementation in Systemic Lupus Erythematosus#851335ClinicalTrials.gov
• The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus#864749ClinicalTrials.gov
• A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus#889856ClinicalTrials.gov
• Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus#967938ClinicalTrials.gov